A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults
Clinical trial NCT04090658 · COMPLETED
Trial details
- NCT number
- NCT04090658
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-25
- Primary completion
- 2020-01-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.